Background Non-medical prescription opioid use (NMPOU) and prescription opioid (PO) related harms have become major substance use and public health problems in North America, the region with the world’s highest PO use levels. In Ontario, Canada’s most populous province, NMPOU rates, PO-related treatment admissions and accidental mortality have risen sharply in recent years. A series of recent policy interventions from governmental and non-governmental entities to stem PO-related problems have been implemented since 2010. Findings We compared the prevalence of NMPOU in the Ontario general adult population (18 years+) in 2010 and 2011 based on data from the ‘Centre for Addiction and Mental Health (CAMH) Monitor’ (CM), a long-standing annual t...
To examine the impact of national clinical practice guidelines and provincial drug policy interventi...
Background Nonmedical prescription opioid use (NMPOU) is a serious public health problem in North Am...
Background Into the 21st century, the conflation of high rates of chronic pain, systemic gaps in tre...
Abstract Background Non-medical prescription opioid u...
Background Morbidity and mortality related to Prescription Opioid Analgesics (POAs) have been rising...
Background Prescription opioid analgesic (POA) utilization has steeply increased globally, yet is fa...
Background: The prevalence and harms associated with nonmedical prescription opioid use (NMPOU) have...
Abstract The magnitude and consequences of prescription opioid (PO) misuse and harms (...
Abstract Background Morbidity and mortality related to Prescription Opioid Analgesics (POAs) have be...
<div><p>Aims</p><p>To examine the impact of national clinical practice guidelines and provincial dru...
1 several authors of the current paper published a commentary in this journal characterizing the eme...
Abstract Background Morbidity and mortality related t...
Background Consumption levels of prescription opioids (POs) have increased substantially worldwide, ...
To examine the impact of national clinical practice guidelines and provincial drug policy interventi...
To examine the impact of national clinical practice guidelines and provincial drug policy interventi...
To examine the impact of national clinical practice guidelines and provincial drug policy interventi...
Background Nonmedical prescription opioid use (NMPOU) is a serious public health problem in North Am...
Background Into the 21st century, the conflation of high rates of chronic pain, systemic gaps in tre...
Abstract Background Non-medical prescription opioid u...
Background Morbidity and mortality related to Prescription Opioid Analgesics (POAs) have been rising...
Background Prescription opioid analgesic (POA) utilization has steeply increased globally, yet is fa...
Background: The prevalence and harms associated with nonmedical prescription opioid use (NMPOU) have...
Abstract The magnitude and consequences of prescription opioid (PO) misuse and harms (...
Abstract Background Morbidity and mortality related to Prescription Opioid Analgesics (POAs) have be...
<div><p>Aims</p><p>To examine the impact of national clinical practice guidelines and provincial dru...
1 several authors of the current paper published a commentary in this journal characterizing the eme...
Abstract Background Morbidity and mortality related t...
Background Consumption levels of prescription opioids (POs) have increased substantially worldwide, ...
To examine the impact of national clinical practice guidelines and provincial drug policy interventi...
To examine the impact of national clinical practice guidelines and provincial drug policy interventi...
To examine the impact of national clinical practice guidelines and provincial drug policy interventi...
Background Nonmedical prescription opioid use (NMPOU) is a serious public health problem in North Am...
Background Into the 21st century, the conflation of high rates of chronic pain, systemic gaps in tre...